Cocrystal Pharma (COCP.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Dec18

Cocrystal Pharma Inc. Begins Phase 1b Study of Oral Antiviral Drug Candidate CDI-988 for Norovirus Infection

13:02

Nov15

Cocrystal Pharma released FY2025 9 Months Earnings on November 14 EST, with actual revenue of USD 0 and EPS of USD -0.6145

04:00

Cocrystal Pharma released FY2025 Q3 earnings on November 14, 2025 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.1864 (forecast USD -0.215)

04:00

Oct27

Cocrystal Pharma Receives NIH Funding to Advance Influenza Inhibitor Program

18:07

Oct23

LeBoyer's Recommended Healthcare Stocks Performance

13:56

Oct9

Cocrystal Pharma Inc. Releases Presentation on Broad-Spectrum Antiviral Drug Development

17:58

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.049 M, EPS -0.1864

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.055 M, EPS -0.2019

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -2.301 M, EPS -0.2261

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More